People with type 1 or insulin-requiring type 2 diabetes in the U.S. can now wear MiniMed’s smallest pump, paired with the Simplera Sync™ sensor NORTHRIDGE, Calif., June 17, 2026 /PRNewswire/ — MiniMed (Nasdaq: MMED), today announced its first commercial launch of the MiniMed Flex™ system in the United States — its first app-controlled pump and the company’s smallest insulin pump yet. The system launches with Simplera Sync™ sensor, a disposable, all-in-one sensor with easy two-step insertion. The launch with the Instinct sensor, made by Abbott, will follow later this summer.* For years, people who use insulin pumps have had to […]

People with type 1 or insulin-requiring type 2 diabetes in the U.S. can now wear MiniMed's smallest pump, paired with the Simplera Sync™ sensor NORTHRIDGE, Calif., June 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), today announced its first commercial launch of the MiniMed Flex™ system...

Continued momentum through the second half of the fiscal year 2026, driven by Simplera™ and Instinct sensor, made by Abbott, CGM launches Worldwide net sales of $837 million grew 15.6% as reported and 8.7% organic International net sales of $599 million grew 22.4% as reported and 12.2% organic, driven by Simplera capacity expansion; International New Pumps...

A decades-old superconducting mystery just took a surprising turn. Strontium ruthenate, a material that conducts electricity with zero resistance at low temperatures, has long puzzled scientists with hints of an exotic, complex superconducting state. But by carefully twisting and distorting ultra-thin crystals, researchers found something unexpected: the material barely reacted at all. This challenges years of assumptions and suggests its behavior may be far simpler—or far stranger—than previously thought.

MiniMed (Nasdaq: MMED) announced FDA clearance of MiniMed Flex™ on March 18, 2026, a screenless, smartphone‑controlled insulin pump about half the size of the 780G with a 300‑unit reservoir. The pump uses SmartGuard™ with Meal Detection™ and demonstrated 80% Time in Range in real‑world results.Commercial launch will pair Flex with Simplera Sync™ and Abbott Instinct sensors, begin a select customer phase this spring, and expand broadly in summer. Eligible 780G users can upgrade via the MiniMed™ Forward Program for $0.

Medtronic (NYSE:MDT) announced today that it launched its MiniMed Go smart multiple daily injection (MDI) system with the Simplera sensor.

Medtronic unveils the MiniMed Go Smart MDI system in Europe, integrating Simplera sensor for enhanced diabetes management. This innovation aims to aid users in their daily injections and offers real-time insights.

Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the...

Recipient Fraud not the Problem

How Migrants Learn and Integrate in Australia

In this episode, hosts explore updates on continuous glucose monitoring (CGM) systems from April 2025.

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous glucose monitor, following 

In this week’s issue of The Savvy Diabetic:  Arkansas Passes Law Barring PBMs From Owning Pharmacies NovoMix 30 and Other Brands Discontinued in India Medtronic Gets FDA Approvals for In…

The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.